OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer
Janet E. Murphy, Jennifer Y. Wo, David P. Ryan, et al.
JAMA Oncology (2019) Vol. 5, Iss. 7, pp. 1020-1020
Open Access | Times Cited: 430
Janet E. Murphy, Jennifer Y. Wo, David P. Ryan, et al.
JAMA Oncology (2019) Vol. 5, Iss. 7, pp. 1020-1020
Open Access | Times Cited: 430
Showing 1-25 of 430 citing articles:
A framework for advancing our understanding of cancer-associated fibroblasts
Erik Sahai, Igor Astsaturov, Edna Cukierman, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 3, pp. 174-186
Open Access | Times Cited: 2733
Erik Sahai, Igor Astsaturov, Edna Cukierman, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 3, pp. 174-186
Open Access | Times Cited: 2733
Therapeutic Targeting of the Tumor Microenvironment
Leire Bejarano, Marta Joana Costa Jordão, Johanna A. Joyce
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 933-959
Open Access | Times Cited: 1062
Leire Bejarano, Marta Joana Costa Jordão, Johanna A. Joyce
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 933-959
Open Access | Times Cited: 1062
Smart cancer nanomedicine
Roy van der Meel, Einar Sulheim, Yang Shi, et al.
Nature Nanotechnology (2019) Vol. 14, Iss. 11, pp. 1007-1017
Open Access | Times Cited: 1014
Roy van der Meel, Einar Sulheim, Yang Shi, et al.
Nature Nanotechnology (2019) Vol. 14, Iss. 11, pp. 1007-1017
Open Access | Times Cited: 1014
The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities
Won Jin Ho, Elizabeth M. Jaffee, Lei Zheng
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 9, pp. 527-540
Open Access | Times Cited: 872
Won Jin Ho, Elizabeth M. Jaffee, Lei Zheng
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 9, pp. 527-540
Open Access | Times Cited: 872
Diversity and Biology of Cancer-Associated Fibroblasts
Giulia Biffi, David A. Tuveson
Physiological Reviews (2020) Vol. 101, Iss. 1, pp. 147-176
Open Access | Times Cited: 826
Giulia Biffi, David A. Tuveson
Physiological Reviews (2020) Vol. 101, Iss. 1, pp. 147-176
Open Access | Times Cited: 826
The matrix in cancer
Thomas R. Cox
Nature reviews. Cancer (2021) Vol. 21, Iss. 4, pp. 217-238
Closed Access | Times Cited: 671
Thomas R. Cox
Nature reviews. Cancer (2021) Vol. 21, Iss. 4, pp. 217-238
Closed Access | Times Cited: 671
Pancreatic cancer stroma: an update on therapeutic targeting strategies
Abdel Hosein, Rolf A. Brekken, Anirban Maitra
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 8, pp. 487-505
Open Access | Times Cited: 664
Abdel Hosein, Rolf A. Brekken, Anirban Maitra
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 8, pp. 487-505
Open Access | Times Cited: 664
Physical traits of cancer
Hadi T. Nia, Lance L. Munn, Rakesh K. Jain
Science (2020) Vol. 370, Iss. 6516
Open Access | Times Cited: 579
Hadi T. Nia, Lance L. Munn, Rakesh K. Jain
Science (2020) Vol. 370, Iss. 6516
Open Access | Times Cited: 579
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
John D. Martin, Horacio Cabral, Triantafyllos Stylianopoulos, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 4, pp. 251-266
Open Access | Times Cited: 535
John D. Martin, Horacio Cabral, Triantafyllos Stylianopoulos, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 4, pp. 251-266
Open Access | Times Cited: 535
Chemoresistance in Pancreatic Cancer
Siyuan Zeng, Marina Pöttler, Bin Lan, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4504-4504
Open Access | Times Cited: 504
Siyuan Zeng, Marina Pöttler, Bin Lan, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4504-4504
Open Access | Times Cited: 504
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Fanglong Wu, Jin Yang, Junjiang Liu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 446
Fanglong Wu, Jin Yang, Junjiang Liu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 446
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Aaron J. Grossberg, Linda C. Chu, Christopher R. Deig, et al.
CA A Cancer Journal for Clinicians (2020) Vol. 70, Iss. 5, pp. 375-403
Open Access | Times Cited: 359
Aaron J. Grossberg, Linda C. Chu, Christopher R. Deig, et al.
CA A Cancer Journal for Clinicians (2020) Vol. 70, Iss. 5, pp. 375-403
Open Access | Times Cited: 359
The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities
Christiana M. Neophytou, Myrofora Panagi, Triantafyllos Stylianopoulos, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2053-2053
Open Access | Times Cited: 305
Christiana M. Neophytou, Myrofora Panagi, Triantafyllos Stylianopoulos, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2053-2053
Open Access | Times Cited: 305
Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer
Ying Shen, Xiaohong Wang, Junyan Lu, et al.
Cancer Cell (2020) Vol. 37, Iss. 6, pp. 800-817.e7
Open Access | Times Cited: 255
Ying Shen, Xiaohong Wang, Junyan Lu, et al.
Cancer Cell (2020) Vol. 37, Iss. 6, pp. 800-817.e7
Open Access | Times Cited: 255
Microenvironmental Determinants of Pancreatic Cancer
Elisabeth Heßmann, S Buchholz, İhsan Ekin Demir, et al.
Physiological Reviews (2020) Vol. 100, Iss. 4, pp. 1707-1751
Closed Access | Times Cited: 231
Elisabeth Heßmann, S Buchholz, İhsan Ekin Demir, et al.
Physiological Reviews (2020) Vol. 100, Iss. 4, pp. 1707-1751
Closed Access | Times Cited: 231
Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer
Marilyne Labrie, Joan S. Brugge, Gordon B. Mills, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 323-339
Open Access | Times Cited: 223
Marilyne Labrie, Joan S. Brugge, Gordon B. Mills, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 323-339
Open Access | Times Cited: 223
Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment
William L. Hwang, Karthik A. Jagadeesh, Jimmy A. Guo, et al.
Nature Genetics (2022) Vol. 54, Iss. 8, pp. 1178-1191
Open Access | Times Cited: 223
William L. Hwang, Karthik A. Jagadeesh, Jimmy A. Guo, et al.
Nature Genetics (2022) Vol. 54, Iss. 8, pp. 1178-1191
Open Access | Times Cited: 223
Translational advances in pancreatic ductal adenocarcinoma therapy
Abdel Hosein, Stephanie K. Dougan, Andrew J. Aguirre, et al.
Nature Cancer (2022) Vol. 3, Iss. 3, pp. 272-286
Open Access | Times Cited: 175
Abdel Hosein, Stephanie K. Dougan, Andrew J. Aguirre, et al.
Nature Cancer (2022) Vol. 3, Iss. 3, pp. 272-286
Open Access | Times Cited: 175
DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives
Lukas Perkhofer, Johann Gout, Élodie Roger, et al.
Gut (2020) Vol. 70, Iss. 3, pp. 606-617
Open Access | Times Cited: 153
Lukas Perkhofer, Johann Gout, Élodie Roger, et al.
Gut (2020) Vol. 70, Iss. 3, pp. 606-617
Open Access | Times Cited: 153
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 142
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 142
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
Volker Kunzmann, Jens T. Siveke, Hana Algül, et al.
The Lancet. Gastroenterology & hepatology (2020) Vol. 6, Iss. 2, pp. 128-138
Closed Access | Times Cited: 139
Volker Kunzmann, Jens T. Siveke, Hana Algül, et al.
The Lancet. Gastroenterology & hepatology (2020) Vol. 6, Iss. 2, pp. 128-138
Closed Access | Times Cited: 139
Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy
Raisa A. Glabman, Peter L. Choyke, Noriko Sato
Cancers (2022) Vol. 14, Iss. 16, pp. 3906-3906
Open Access | Times Cited: 137
Raisa A. Glabman, Peter L. Choyke, Noriko Sato
Cancers (2022) Vol. 14, Iss. 16, pp. 3906-3906
Open Access | Times Cited: 137
Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies
Luman Liu, Prakash Kshirsagar, Shailendra K. Gautam, et al.
Theranostics (2022) Vol. 12, Iss. 3, pp. 1030-1060
Open Access | Times Cited: 81
Luman Liu, Prakash Kshirsagar, Shailendra K. Gautam, et al.
Theranostics (2022) Vol. 12, Iss. 3, pp. 1030-1060
Open Access | Times Cited: 81
Controlling the biodistribution and clearance of nanomedicines
Horacio Cabral, Junjie Li, Kanjiro Miyata, et al.
Nature Reviews Bioengineering (2023) Vol. 2, Iss. 3, pp. 214-232
Closed Access | Times Cited: 78
Horacio Cabral, Junjie Li, Kanjiro Miyata, et al.
Nature Reviews Bioengineering (2023) Vol. 2, Iss. 3, pp. 214-232
Closed Access | Times Cited: 78
The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets
Jelle J. F. Sleeboom, Gilles S. van Tienderen, Katja Schenke‐Layland, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 728
Closed Access | Times Cited: 78
Jelle J. F. Sleeboom, Gilles S. van Tienderen, Katja Schenke‐Layland, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 728
Closed Access | Times Cited: 78
